@article{233d89d699c342b9bdf89bb764a5edfc,
title = "Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology",
abstract = "We performed a systematic review of long-term studies on drugs, metabolic diseases and dietary factors, and risk of prostate cancer considering the impact of prostate-specific antigen testing and found low-quality evidence of modest effects for some of them.",
keywords = "Alpha reductase inhibitor, Aspirin, Body mass index, Diabetes, Diet, Food, Metabolic syndrome, Metformin, Nonsteroidal anti-inflammatory drugs, Obesity, Prostate cancer, Prostate-specific antigen test, Statin, Alpha reductase inhibitor, Aspirin, Body mass index, Diabetes, Diet, Food, Metabolic syndrome, Metformin, Nonsteroidal anti-inflammatory drugs, Obesity, Prostate cancer, Prostate-specific antigen test, Statin",
author = "R. Campi and Brookman-May, \{S. D.\} and Subiela, \{Henriquez J. D.\} and B. Akdogan and M. Brausi and T. Klatte and Langenhuijsen, \{J. F.\} and E. Linares-Espinos and M. Marszalek and M. Roupret and Stief, \{C. G.\} and Alessandro VOLPE and A. Minervini and O. Rodriguez-Faba",
note = "Publisher Copyright: {\textcopyright} 2018 European Association of Urology",
year = "2019",
doi = "10.1016/j.euf.2018.04.001",
language = "English",
volume = "5",
pages = "1029--1057",
journal = "European Urology Focus",
issn = "2405-4569",
publisher = "Elsevier BV",
number = "6",
}